Retatrutide Is Being Called the "Godzilla" of Weight Loss — Here's What Phase 3 Trials Just Revealed
Retatrutide produced 28.7% mean weight loss in its first Phase 3 readout. Here's what TRIUMPH-4 actually showed and what it didn't.
SURMOUNT-5 settled the indirect-comparison era. Here is what the head-to-head trial actually showed about tirzepatide versus semaglutide for fat loss.

Retatrutide produced 28.7% mean weight loss in its first Phase 3 readout. Here's what TRIUMPH-4 actually showed and what it didn't.
GLP-1 microdosing is everywhere in 2026. Here is what the evidence actually shows about sub-therapeutic semaglutide and tirzepatide doses.
After the FDA declared the semaglutide shortage resolved in February 2025, the legal market for compounded GLP-1s narrowed sharply while a black market expanded. This guide walks through 503A vs 503B vs research peptides, the salt-form red flag, counterfeit incidents on record, and the credentialing checklist and questions that separate a legitimate compounding pharmacy from a dangerous knockoff.
AOD-9604 is sold as fat loss without hunger. The 24-week trial in 536 people that was supposed to confirm it failed in 2007. Here is what the evidence actually shows.
Research shows weighted vest walking burns more calories proportional to load and may help maintain bone density -- but only during structured exercise, not passive wear.
OTC glucose monitors, vitamin patches, and biosensor innovations are reshaping personal health tracking. Here's what works, what doesn't, and what's next.
A meta-analysis of 351 participants found treadmill desks burn 105 extra calories per hour. But Consumer Reports only recommended 1 of 9 models tested.
A research-backed comparison of three screenless health trackers, with PSG validation data, real-world battery tests, and a cost breakdown over three years.
UCSF researchers found that chronic stress accelerates cellular aging. The slowmaxxing movement uses evidence-backed habits to fight back.

An evidence-based guide to vitamin E for skin, covering how it works, which forms matter, and what dermatologists say about gummies and the TikTok capsule trend.
SURMOUNT-5 settled the indirect-comparison era.
Here is what the head-to-head trial actually showed about tirzepatide versus semaglutide for fat loss.
The goal isn’t to be comfortable with change — it’s to be comfortable with one small change, on a schedule, held for a year.
We’re recording with NotebookLM. Expect a deep-dive and a short-form version of each issue’s best essays, delivered to your favorite podcast app when we launch.